These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 18540893)
1. Putting the shoe on the wrong foot: a reply to Ponder and Srivastava. Kimmelman J Haemophilia; 2008 Sep; 14(5):1112-4. PubMed ID: 18540893 [No Abstract] [Full Text] [Related]
2. Walk a mile in the moccasins of people with haemophilia. Ponder KP; Srivastava A Haemophilia; 2008 May; 14(3):618-20. PubMed ID: 18248409 [No Abstract] [Full Text] [Related]
3. Gene therapy for hemophilia A and B: patient selection and follow-up, requirements for a cure. Lusher JM Thromb Haemost; 1999 Aug; 82(2):572-5. PubMed ID: 10605753 [No Abstract] [Full Text] [Related]
4. Clinical trials and SCID row: the ethics of phase 1 trials in the developing world. Kimmelman J Dev World Bioeth; 2007 Dec; 7(3):128-35. PubMed ID: 18021117 [TBL] [Abstract][Full Text] [Related]
5. Undue fear of inducements in research in developing countries. Arnason G; Van Niekerk A Camb Q Healthc Ethics; 2009 Apr; 18(2):122-9. PubMed ID: 19250565 [No Abstract] [Full Text] [Related]
6. Gene therapy for hemophilia: clinical trials and technical tribulations. Viiala NO; Larsen SR; Rasko JE Semin Thromb Hemost; 2009 Feb; 35(1):81-92. PubMed ID: 19308896 [TBL] [Abstract][Full Text] [Related]
11. The promise and pitfalls of clinical trials overseas. Normile D Science; 2008 Oct; 322(5899):214-6. PubMed ID: 18845744 [No Abstract] [Full Text] [Related]
12. Ethical aspects of clinical trials in gene therapy. Pandya SK Issues Med Ethics; 2000; 8(4):122-4. PubMed ID: 16323376 [No Abstract] [Full Text] [Related]
13. Endpoints in clinical trials involving hemostasis and bleeding in patients with hemophilia. Escobar MA Transfusion; 2005 Jul; 45(1 Suppl):2S-3S. PubMed ID: 15989684 [No Abstract] [Full Text] [Related]
14. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy. Youjin S; Jun Y Biotechnol Lett; 2009 Mar; 31(3):321-8. PubMed ID: 18979215 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic therapy programs for hemophilia in developing countries. Willoughby ML Pediatr Hematol Oncol; 1997; 14(2):ix-xii. PubMed ID: 9089735 [No Abstract] [Full Text] [Related]
16. [Clinical trials in developing countries: who should define ethics?]. Béréterbide F; Hirsch F Bull Soc Pathol Exot; 2008 Apr; 101(2):102-5. PubMed ID: 18543701 [TBL] [Abstract][Full Text] [Related]
17. Unabated increases in trial costs reflect evolving research milieu. Samson K Ann Neurol; 2009 Apr; 65(4):A9-11. PubMed ID: 19399857 [No Abstract] [Full Text] [Related]
18. Benefits to research subjects in international trials: do they reduce exploitation or increase undue inducement? Ballantyne A Dev World Bioeth; 2008 Dec; 8(3):178-91. PubMed ID: 19046255 [TBL] [Abstract][Full Text] [Related]
19. Putting Norway on the gene-therapy map. Myklebost O Nature; 2004 May; 429(6988):129. PubMed ID: 15141186 [No Abstract] [Full Text] [Related]
20. Guinea-pigging. Elliott C Minn Med; 2008 Apr; 91(4):32-6. PubMed ID: 18549005 [No Abstract] [Full Text] [Related] [Next] [New Search]